EmbryoGlue® ökar chansen för infertila att få barn

2011-07-05 - 10:30

En studie som visar att signifikant fler (63%) patienter fick barn när EmbryoGlue® användes, jämfört med kontrollgruppen, presenterades vid den pågående ESHRE-konferensen i Stockholm. Vitrolifes patenterade medium EmbryoGlue® används vid återförande av embryon i samband med assisterad befruktning.

We have now shown that EmbryoGlue® results in more babies being born compared with traditional products, irrespective of the day when the embryos are reintroduced, says Dr. Basak Balaban, who works at the American Hospital in Istanbul, Turkey.

The independent Cochrane report has previously shown that EmbryoGlue® has a positive effect on pregnancy frequency.

The study results were presented at the annual ESHRE conference (European Society of Human Reproduction and Embryology) that is being held in Stockholm this year. The conference started on Sunday and has brought together approximately 8,000 delegates from all over the world.

EmbryoGlue® is a patented product with a unique composition that includes hyaluronic acid and it is similar to the natural environment in the womb. The components that it contains provide the embryo with the necessary nutrients and sources of energy and make it easier for the reintroduced embryos to attach to the endometrium and develop into a foetus.

July 5, 2011


Magnus Nilsson



VD Magnus Nilsson, telefon 031-721 80 61

Ekonomi- och informationschef Anne-Lie Sveder, telefon 031-721 80 13